-
1تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: Covens A, Filiaci VL, Burger RA, Osborne R, Chen MD; Gynecologic Oncology Group. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study. Cancer. 2006 Sep 15;107(6):1280-6. doi: 10.1002/cncr.22118.
Pulse Actinomycin-D as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Neoplasiaالوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00003688Test
-
2تقرير
المصدر: A Randomized Phase III Trial of Weekly Parenteral Methotrexate Versus "Pulsed" Dactinomycin as Primary Management for Low Risk Gestational Trophoblastic Neoplasia
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00003702Test
-
3تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: A Randomized Phase III Trial of Amifostine vs. No Treatment for Platinum Induced Peripheral Neuropathy
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00058071Test
-
4تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: A Phase II Trial of Pemetrexed (ALIMTA®, LY231514, IND #40061) as Salvage Therapy for Failed Low Risk Gestational Trophoblastic Tumor
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00096187Test
-
5تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: A Phase II Study to Determine the Response to Second Curettage as Initial Management for Persistent Low Risk, Non-metastatic Gestational Trophoblastic Neoplasia
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00521118Test
-
6تقرير
المؤلفون: National Cancer Institute (NCI)
المصدر: Acquisition of Human Gynecologic Specimens to be Used in Studying the Causes, Diagnosis, Prevention and Treatment of Cancer
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00897442Test